Skip to main content
NCBI home page
Infection and Immunity logoLink to Infection and Immunity
. 1990 Nov;58(11):3679–3688. doi: 10.1128/iai.58.11.3679-3688.1990

Variable antigens of Ureaplasma urealyticum containing both serovar-specific and serovar-cross-reactive epitopes.

H L Watson 1, D K Blalock 1, G H Cassell 1
PMCID: PMC313714  PMID: 1699897

Abstract

Currently there are 14 recognized serovars of Ureaplasma urealyticum, and it has been postulated that only certain ones may be associated with disease and that lack of serovar-specific antibody may be an important risk factor. Unfortunately, ureaplasma antigens important in the human immune response and disease pathogenesis are poorly defined. By using sera from ureaplasma-infected patients and antiureaplasma monoclonal antibodies, the present study has demonstrated, for serovars 3, 8, and 10, antigens which (i) are species specific, (ii) contain both serovar-specific and cross-reactive epitope(s), (iii) are produced not only in vitro but also in vivo, (iv) undergo a high rate of structural variation in vitro, (v) are present and structurally variable on invasive ureaplasma isolates (i.e., those from placenta, lung, and cerebrospinal fluid), and (vi) are among the predominant antigens recognized during infections in humans. Furthermore, we have shown that monoclonal antibodies to these antigens can inhibit the growth of the organisms in vitro, indicating the potential for these antigens to be important for host defense.

Full text

PDF
3679

Images in this article

3681Image
on p.3681
3682Image
on p.3682
3683Image
on p.3683
3684Image
on p.3684
3685Image
on p.3685

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ballow M., Cates K. L., Rowe J. C., Goetz C., Desbonnet C. Development of the immune system in very low birth weight (less than 1500 g) premature infants: concentrations of plasma immunoglobulins and patterns of infections. Pediatr Res. 1986 Sep;20(9):899–904. doi: 10.1203/00006450-198609000-00019. [DOI] [PubMed] [Google Scholar]
  2. Blanchard A. Ureaplasma urealyticum urease genes; use of a UGA tryptophan codon. Mol Microbiol. 1990 Apr;4(4):669–676. doi: 10.1111/j.1365-2958.1990.tb00636.x. [DOI] [PubMed] [Google Scholar]
  3. Cassell G. H., Crouse D. T., Waites K. B., Rudd P. T., Davis J. K. Does Ureaplasma urealyticum cause respiratory disease in newborns? Pediatr Infect Dis J. 1988 Aug;7(8):535–541. [PubMed] [Google Scholar]
  4. Cassell G. H., Davis R. O., Waites K. B., Brown M. B., Marriott P. A., Stagno S., Davis J. K. Isolation of Mycoplasma hominis and Ureaplasma urealyticum from amniotic fluid at 16-20 weeks of gestation: potential effect on outcome of pregnancy. Sex Transm Dis. 1983 Oct-Dec;10(4 Suppl):294–302. [PubMed] [Google Scholar]
  5. Cassell G. H., Waites K. B., Crouse D. T., Rudd P. T., Canupp K. C., Stagno S., Cutter G. R. Association of Ureaplasma urealyticum infection of the lower respiratory tract with chronic lung disease and death in very-low-birth-weight infants. Lancet. 1988 Jul 30;2(8605):240–245. doi: 10.1016/s0140-6736(88)92536-6. [DOI] [PubMed] [Google Scholar]
  6. Cassell G. H., Waites K. B., Gibbs R. S., Davis J. K. Role of Ureaplasma urealyticum in amnionitis. Pediatr Infect Dis. 1986 Nov-Dec;5(6 Suppl):S247–S252. doi: 10.1097/00006454-198611010-00009. [DOI] [PubMed] [Google Scholar]
  7. Cassell G. H., Watson H. L., Blalock D. K., Horowitz S. A., Duffy L. B. Protein antigens of genital mycoplasmas. Rev Infect Dis. 1988 Jul-Aug;10 (Suppl 2):S391–S398. doi: 10.1093/cid/10.supplement_2.s391. [DOI] [PubMed] [Google Scholar]
  8. Cassell G. H., Younger J. B., Brown M. B., Blackwell R. E., Davis J. K., Marriott P., Stagno S. Microbiologic study of infertile women at the time of diagnostic laparoscopy. Association of Ureaplasma urealyticum with a defined subpopulation. N Engl J Med. 1983 Mar 3;308(9):502–505. doi: 10.1056/NEJM198303033080906. [DOI] [PubMed] [Google Scholar]
  9. Cates K. L., Rowe J. C., Ballow M. The premature infant as a compromised host. Curr Probl Pediatr. 1983 Jun;13(8):1–63. doi: 10.1016/0045-9380(83)90008-7. [DOI] [PubMed] [Google Scholar]
  10. Dybvig K., Alderete J., Watson H. L., Cassell G. H. Adsorption of mycoplasma virus P1 to host cells. J Bacteriol. 1988 Sep;170(9):4373–4375. doi: 10.1128/jb.170.9.4373-4375.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Dybvig K., Simecka J. W., Watson H. L., Cassell G. H. High-frequency variation in Mycoplasma pulmonis colony size. J Bacteriol. 1989 Sep;171(9):5165–5168. doi: 10.1128/jb.171.9.5165-5168.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Horowitz S. A., Duffy L., Garrett B., Stephens J., Davis J. K., Cassell G. H. Can group- and serovar-specific proteins be detected in Ureaplasma urealyticum? Pediatr Infect Dis. 1986 Nov-Dec;5(6 Suppl):S325–S331. doi: 10.1097/00006454-198611010-00029. [DOI] [PubMed] [Google Scholar]
  13. Horowitz S. A., Garrett B., Davis J. K., Cassell G. H. Isolation of Mycoplasma pulmonis membranes and identification of surface antigens. Infect Immun. 1987 May;55(5):1314–1320. doi: 10.1128/iai.55.5.1314-1320.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Krause D. C., Leith D. K., Wilson R. M., Baseman J. B. Identification of Mycoplasma pneumoniae proteins associated with hemadsorption and virulence. Infect Immun. 1982 Mar;35(3):809–817. doi: 10.1128/iai.35.3.809-817.1982. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. LOWRY O. H., ROSEBROUGH N. J., FARR A. L., RANDALL R. J. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951 Nov;193(1):265–275. [PubMed] [Google Scholar]
  16. Lee G. Y., Kenny G. E. Humoral immune response to polypeptides of Ureaplasma urealyticum in women with postpartum fever. J Clin Microbiol. 1987 Oct;25(10):1841–1844. doi: 10.1128/jcm.25.10.1841-1844.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Mouches C., Taylor-Robinson D., Stipkovits L., Bove J. M. Comparison of human and animal Ureaplasmas by one- and two-dimensional protein analysis on polyacrylamide slab gel. Ann Microbiol (Paris) 1981 Sep-Oct;132B(2):171–196. [PubMed] [Google Scholar]
  18. Quinn P. A., Rubin S., Nocilla D. M., Read S. E., Chipman M. Serological evidence of Ureaplasma urealyticum infection in neonatal respiratory disease. Yale J Biol Med. 1983 Sep-Dec;56(5-6):565–572. [PMC free article] [PubMed] [Google Scholar]
  19. Quinn P. A., Shewchuk A. B., Shuber J., Lie K. I., Ryan E., Sheu M., Chipman M. L. Serologic evidence of ureaplasma urealyticum infection in women with spontaneous pregnancy loss. Am J Obstet Gynecol. 1983 Jan 15;145(2):245–250. doi: 10.1016/0002-9378(83)90500-8. [DOI] [PubMed] [Google Scholar]
  20. Razin S., Yogev D. Genetic relatedness among Ureaplasma urealyticum serotypes (serovars). Pediatr Infect Dis. 1986 Nov-Dec;5(6 Suppl):S300–S304. doi: 10.1097/00006454-198611010-00022. [DOI] [PubMed] [Google Scholar]
  21. Robertson J. A., Chen M. H. Effects of manganese on the growth and morphology of Ureaplasma urealyticum. J Clin Microbiol. 1984 Jun;19(6):857–864. doi: 10.1128/jcm.19.6.857-864.1984. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Rosengarten R., Wise K. S. Phenotypic switching in mycoplasmas: phase variation of diverse surface lipoproteins. Science. 1990 Jan 19;247(4940):315–318. doi: 10.1126/science.1688663. [DOI] [PubMed] [Google Scholar]
  23. Rudd P. T., Cassell G. H., Waites K. B., Davis J. K., Duffy L. B. Ureaplasma urealyticum pneumonia: experimental production and demonstration of age-related susceptibility. Infect Immun. 1989 Mar;57(3):918–925. doi: 10.1128/iai.57.3.918-925.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Sasaki T., Sasaki Y., Matsumura T., Oyama N., Koshimizu K. Characterization of a strain of Mycoplasma hominis lacking 120 kDa membrane protein isolated from Vero cell culture. Microbiol Immunol. 1989;33(5):423–427. doi: 10.1111/j.1348-0421.1989.tb01990.x. [DOI] [PubMed] [Google Scholar]
  25. Talkington D. F., Fallon M. T., Watson H. L., Thorp R. K., Cassell G. H. Mycoplasma pulmonis V-1 surface protein variation: occurrence in vivo and association with lung lesions. Microb Pathog. 1989 Dec;7(6):429–436. doi: 10.1016/0882-4010(89)90023-5. [DOI] [PubMed] [Google Scholar]
  26. Taylor-Robinson D., Furr P. M., Webster A. D. Ureaplasma urealyticum in the immunocompromised host. Pediatr Infect Dis. 1986 Nov-Dec;5(6 Suppl):S236–S238. doi: 10.1097/00006454-198611010-00006. [DOI] [PubMed] [Google Scholar]
  27. Thirkell D., Myles A. D., Russell W. C. Serotype 8- and serocluster-specific surface-expressed antigens of Ureaplasma urealyticum. Infect Immun. 1989 Jun;57(6):1697–1701. doi: 10.1128/iai.57.6.1697-1701.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Towbin H., Staehelin T., Gordon J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci U S A. 1979 Sep;76(9):4350–4354. doi: 10.1073/pnas.76.9.4350. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Ureaplasmas of humans: with emphasis upon maternal and neonatal infections. Proceedings of an international symposium of the International Organization for Mycoplasmology. Seattle, Washington, October 10-12, 1985. Tribute to Dr. Maurice Charles Shepard. Pediatr Infect Dis. 1986 Nov-Dec;5(6 Suppl):S221–S354. [PubMed] [Google Scholar]
  30. Vogler L. B., Waites K. B., Wright P. F., Perrin J. M., Cassell G. H. Ureaplasma urealyticum polyarthritis in agammaglobulinemia. Pediatr Infect Dis. 1985 Nov-Dec;4(6):687–691. doi: 10.1097/00006454-198511000-00020. [DOI] [PubMed] [Google Scholar]
  31. Waites K. B., Rudd P. T., Crouse D. T., Canupp K. C., Nelson K. G., Ramsey C., Cassell G. H. Chronic Ureaplasma urealyticum and Mycoplasma hominis infections of central nervous system in preterm infants. Lancet. 1988 Jan 2;1(8575-6):17–21. doi: 10.1016/s0140-6736(88)91002-1. [DOI] [PubMed] [Google Scholar]
  32. Watson H. L., Davidson M. K., Cox N. R., Davis J. K., Dybvig K., Cassell G. H. Protein variability among strains of Mycoplasma pulmonis. Infect Immun. 1987 Nov;55(11):2838–2840. doi: 10.1128/iai.55.11.2838-2840.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Watson H. L., Dybvig K., Blalock D. K., Cassell G. H. Subunit structure of the variable V-1 antigen of Mycoplasma pulmonis. Infect Immun. 1989 Jun;57(6):1684–1690. doi: 10.1128/iai.57.6.1684-1690.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Watson H. L., McDaniel L. S., Blalock D. K., Fallon M. T., Cassell G. H. Heterogeneity among strains and a high rate of variation within strains of a major surface antigen of Mycoplasma pulmonis. Infect Immun. 1988 May;56(5):1358–1363. doi: 10.1128/iai.56.5.1358-1363.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Wise K. S., Kim M. F. Major membrane surface proteins of Mycoplasma hyopneumoniae selectively modified by covalently bound lipid. J Bacteriol. 1987 Dec;169(12):5546–5555. doi: 10.1128/jb.169.12.5546-5555.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Infection and Immunity are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES